Materials • Major Chemicals
$1.61 ▼ -0.10
(-5.85%)
MKT CAP: $122.3M • VOL: 2.16M
52W L $1 52W H $5
LODE // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.6M | $3.0M | $1.3M |
| YoY Revenue Growth % | -48.5% | +136.7% | — |
| Gross Profit | -$1.1M | $2.6M | — |
| Gross Margin % | -50.0% | 85.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$38.1M | -$39.7M | -$12.6M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$43.2M | -$53.4M | $10.5M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$24.4M | -$13.9M | -$13.6M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | -$24.4M | -$13.9M | -$13.6M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -33.3% | -45.0% | — |
| Cash & Short-Term Equivalents | $17.0M | $954.3K | — |
| Total Debt (Short + Long Term) | $0 | $8.4M | — |
| Total Stockholders' Equity | $107.6M | $59.8M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR LODE.